Company: IMNN
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001641172-25-013088
Chunk: 3

Company: Imunon, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 3
---
 is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended (the “ Securities Act”). Additional information on the Selling Securityholders, and the times and manner in which they may offer and sell shares of our common stock under this prospectus, is provided under “ Selling Securityholders” and “ Plan of Distribution” in this prospectus.

Our Common Stock is listed on Nasdaq under the symbol “IMNN.” On May 28, 2025, the last reported sale price of our Common Stock was $1.52 per share.

Investing in our securities involves a high degree of risk. You should carefully review the risks and uncertainties referenced under the heading “Risk Factors” beginning on page 5 of this prospectus and in the other documents that are incorporated by reference into this prospectus before purchasing any of the shares offered by this prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is , 2025.</div>

<div align='center'>TABLE OF CONTENTS</div>

| ABOUT THIS PROSPECTUS                                  |     |  1 |
| PROSPECTUS SUMMARY                                     |     |  2 |
| THE OFFERING                                           |     |  4 |
| RISK FACTORS                                           |     |  5 |
| CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS |     |  7 |
| USE OF PROCEEDS                                        |     |  8 |
| DIVIDEND POLICY                                        |     |  9 |
| SELLING SECURITYHOLDERS                                |     | 10 |
| PLAN OF DISTRIBUTION                                   |     | 12 |
| DESCRIPTION OF CAPITAL STOCK                           |     | 14 |
| LEGAL MATTERS                                          |     | 19 |
| EXPERTS                                                |     | 19 |
| WHERE YOU CAN FIND MORE INFORMATION                    |     | 19 |
| INCORPORATION OF CERTAIN INFORMATION BY REFERENCE      |     | 19 |

| i |

<div align='center'>ABOUT THIS PROSPECTUS</div>

As used in this prospectus, unless the context otherwise requires or indicates, references to “the Company,” “we,” “our,” “ourselves,” and “us” refer to Imunon